Personalized Medicine Bioinformatics Market Report 2026

Personalized Medicine Bioinformatics Market Overview

• Personalized Medicine Bioinformatics market size has reached to $3.87 billion in 2025 • Expected to grow to $7.23 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Surge In Personalized Medicine Driving The Growth Of The Market Due To Advancements In Genomic Profiling And Targeted Therapies • Market Trend: AI-Driven Predictive Analytics Platforms Transforming Precision Oncology And Personalized Treatment Strategies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Medicine Bioinformatics Market?

Personalized medicine bioinformatics refers to the application that integrates advanced computational tools and biological data to analyze individual genetic and molecular profiles. It enables precise interpretation of complex biological information to support informed decision-making. PMB enhances the accuracy of medical insights and accelerates the identification of patient-specific strategies. Its core advantage lies in delivering data-driven clarity in understanding individual biological variability. The main technology types of personalized medicine bioinformatics are gene sequencing, genomics-global-market-report" target="_blank">pharmacogenomics, microarray technology, artificial intelligence-driven analytics platforms, and others. Gene sequencing involves determining the precise order of nucleotides in a DNA or RNA molecule to analyze genetic variations that influence individual responses to drugs and therapies. It is applied in areas such as genomics, proteomics, transcriptomics, metabolomics, epigenomics, and others, and is utilized by multiple end-users, including biotechnology and pharmaceutical companies, clinical diagnostics laboratories, hospitals and academic medical centers, contract research organizations and biobanks, and others.

What Is The Personalized Medicine Bioinformatics Market Growth Forecast?

The personalized medicine bioinformatics market size is expected to see rapid growth in the next few years. It will grow to $7.23 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing integration of bioinformatics in clinical workflows, rising investments in personalized medicine programs, expansion of ai-enabled clinical decision support, growing adoption of population-scale genomics analysis, increasing demand for interoperable health data platforms. Major trends in the forecast period include increasing adoption of AI-driven genomic data analytics, rising use of multi-omics data integration platforms, growing demand for cloud-based bioinformatics solutions, expansion of pharmacogenomic decision support tools, enhanced focus on scalable data interpretation frameworks.

Global Personalized Medicine Bioinformatics Market Segmentation

1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, Other Technologies 2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, Other Applications 3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals And Academic Medical Centers, Contact Research Organizations and Biobanks, Other End-Users Subsegments: 1) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS) 2) By Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction (ADR) Prediction, Biomarker Discovery, Personalized Drug Response Profiling 3) By Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization (CGH) Microarray 4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing (NLP) Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems (CDSS) 5) By Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms

What Is The Driver Of The Personalized Medicine Bioinformatics Market?

The growing demand for personalized medicine is expected to propel the growth of the personalized medicine bioinformatics market going forward. Personalized medicine is a medical approach that customizes prevention, diagnosis, and therapy based on an individual’s specific genetic makeup, health condition, and lifestyle factors. Personalized medicine is growing due to genomic and data analytics advancements that enable accurate genetic profiling, allowing more precise treatments with improved outcomes and reduced trial-and-error. Personalized medicine bioinformatics processes genomic and clinical data to reveal insights into individual health conditions, supporting accurate treatment choices and drug response predictions while guiding targeted therapies that enhance tailored patient care. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the personalized medicine bioinformatics industry.

Key Players In The Global Personalized Medicine Bioinformatics Market

Major companies operating in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.

Global Personalized Medicine Bioinformatics Market Trends and Insights

Major companies operating in the personalized medicine bioinformatics market are focusing on developing advanced solutions such as predictive analytics platforms to enhance disease prediction and improve patient outcomes. A predictive analytics platform leverages machine learning, algorithms, and statistical models to analyze historical and real-time data for forecasting outcomes, enabling healthcare providers to anticipate risks, refine treatments, and make proactive decisions. For instance, in April 2023, Certis Oncology Solutions, a US-based biotechnology company, launched CertisAI, a predictive analytics platform. This AI/ML-based platform leverages big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers, aiming to accelerate drug discovery and the development of companion diagnostics in precision oncology. The platform is validating its proprietary approach to predicting therapeutic response and supporting its use as a service accessible to biopharmaceutical companies for enhanced early drug development decisions and personalized cancer treatment strategies.

What Are Latest Mergers And Acquisitions In The Personalized Medicine Bioinformatics Market?

In May 2025, GeneDx Holdings Corp., a US-based provider of genomic testing and diagnostic services, acquired Fabric Genomics for up to $51 million. Through this acquisition, GeneDx aims to strengthen its decentralized, AI-powered genomic interpretation capabilities to accelerate rapid and scalable genomic diagnostics. Fabric Genomics is a US-based provider of AI-driven genomic interpretation software specializing in whole genome sequencing analysis for rare disease, hereditary risk, and cancer testing.

Regional Outlook

North America was the largest region in the personalized medicine bioinformatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Medicine Bioinformatics Market?

The personalized medicine bioinformatics market consists of revenues earned by entities by providing services next-generation sequencing (NGS), interpretation, variant annotation, and multi-omics data integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized medicine bioinformatics market also includes sales of genomic analysis software, variant interpretation and annotation tools, clinical decision support systems, and bioinformatics data management and workflow tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Medicine Bioinformatics Market Report 2026?

The personalized medicine bioinformatics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine bioinformatics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.